Our Journey
2022~2024
Leap Forward Period
2019~2021
Period of Capacity Building
2017~2018
Founding Period
2023
-
Exclusive technology transfer acquired from a government-funded institute for strain KFRI-G001 with gluten-degrading activity
-
Secured technology transfer from a government-funded institute for the BR301 strain for pets and animals
-
Hosted the 12th–14th Microbiome Industrialization Forums
2022
-
Hosted the 11th Microbiome Industrialization Forum
-
Formed an industry–academic technology development MOU with Kwangwoon University Graduate School of Business
2021
-
Acquired strain GLU70 with gluten-degrading properties and related patent
-
Honored with the National Sustainability Management Outstanding Company Award
-
Received the 15th Korea’s Excellent Patent Award
-
Honored with the 2021 Korea Innovation Award
-
Hosted the 9th–10th Microbiome Industrialization Forums
2020
-
Secured a technology transfer agreement for anti-influenza strains with a government-funded institute
-
Secured technology transfer agreements for immune disease prevention and treatment strains
2019
-
Received the 2019 Korea Top Management Award
Commercial launch of "Postbiotics"
-
Commercial launch of "Inbiotics"
-
Established an MOU partnership with Shanghai General Hospital
-
Winner of the Korean Influential Brand Award
-
Hosted the 7th–8th Microbiome Industrialization Forums
-
Co-hosted the 2nd International Microbiome Industrialization Conference (with Dong-A Ilbo)
2018
-
Hosted the 1st–6th Microbiome Industrialization Forums
-
Hosted the 1st International Microbiome Industrialization Conference
-
Commercial launch of “Zenbiotics”
-
Technology transfer of strain MB0601 with gluten-degrading properties
-
Technology transfer agreement signed with a government-funded research institute for the commercial application of high-value strains
-
Secured joint research and development rights with South Korean universities
-
Certified as a venture business
2017
-
Established Microbiome Inc.